Ignite Creation Date:
2025-12-24 @ 4:16 PM
Ignite Modification Date:
2026-01-01 @ 3:27 PM
Study NCT ID:
NCT02937766
Status:
TERMINATED
Last Update Posted:
2022-04-21
First Post:
2016-10-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study Assessing Injection Pain of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) When Administered Via Subcutaneous Auto-injector vs Intramuscular Injection Via Needle and Syringe in Healthy Post-menopausal Women
Sponsor:
AMAG Pharmaceuticals, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Assessing Injection Pain of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) … | View |
Keywords: